394 related articles for article (PubMed ID: 22110478)
1. Role of transcription factor modifications in the pathogenesis of insulin resistance.
Kim MY; Bae JS; Kim TH; Park JM; Ahn YH
Exp Diabetes Res; 2012; 2012():716425. PubMed ID: 22110478
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.
Gaggini M; Morelli M; Buzzigoli E; DeFronzo RA; Bugianesi E; Gastaldelli A
Nutrients; 2013 May; 5(5):1544-60. PubMed ID: 23666091
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in nonalcoholic fatty liver disease.
Bugianesi E; Moscatiello S; Ciaravella MF; Marchesini G
Curr Pharm Des; 2010 Jun; 16(17):1941-51. PubMed ID: 20370677
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
Muzurović E; Mikhailidis DP; Mantzoros C
Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
[TBL] [Abstract][Full Text] [Related]
5. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
Byrne CD
Proc Nutr Soc; 2013 Nov; 72(4):412-9. PubMed ID: 23668723
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance.
Kim SK; Choi YJ; Huh BW; Park SW; Lee EJ; Cho YW; Huh KB
J Clin Endocrinol Metab; 2014 May; 99(5):1879-84. PubMed ID: 24512497
[TBL] [Abstract][Full Text] [Related]
7. Role of transcription factor acetylation in the regulation of metabolic homeostasis.
Park JM; Jo SH; Kim MY; Kim TH; Ahn YH
Protein Cell; 2015 Nov; 6(11):804-13. PubMed ID: 26334401
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments.
Scorletti E; Calder PC; Byrne CD
Endocrine; 2011 Dec; 40(3):332-43. PubMed ID: 21894514
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
10. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
[TBL] [Abstract][Full Text] [Related]
11. [The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease].
Orlik B; Handzlik G; Olszanecka-Glinianowicz M
Postepy Hig Med Dosw (Online); 2010 May; 64():212-9. PubMed ID: 20498498
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease and insulin resistance.
Machado M; Cortez-Pinto H
Eur J Gastroenterol Hepatol; 2005 Aug; 17(8):823-6. PubMed ID: 16003131
[TBL] [Abstract][Full Text] [Related]
13. [Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker].
Chellali S; Boudiba A; Griene L; Koceir EA
Ann Biol Clin (Paris); 2019 Jun; 77(3):261-271. PubMed ID: 30998190
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.
Birkenfeld AL; Shulman GI
Hepatology; 2014 Feb; 59(2):713-23. PubMed ID: 23929732
[TBL] [Abstract][Full Text] [Related]
15. JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease.
Tarantino G; Caputi A
World J Gastroenterol; 2011 Sep; 17(33):3785-94. PubMed ID: 21987620
[TBL] [Abstract][Full Text] [Related]
16. The metabolic abnormalities associated with non-alcoholic fatty liver disease.
Haque M; Sanyal AJ
Best Pract Res Clin Gastroenterol; 2002 Oct; 16(5):709-31. PubMed ID: 12406441
[TBL] [Abstract][Full Text] [Related]
17. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
[TBL] [Abstract][Full Text] [Related]
18. NAFLD, NASH and liver cancer.
Michelotti GA; Machado MV; Diehl AM
Nat Rev Gastroenterol Hepatol; 2013 Nov; 10(11):656-65. PubMed ID: 24080776
[TBL] [Abstract][Full Text] [Related]
19. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes.
Grønbaek H; Thomsen KL; Rungby J; Schmitz O; Vilstrup H
Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):705-11. PubMed ID: 19072347
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih M; Jornayvaz FR
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
